These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 18439109

  • 1. Predominant Ashkenazi BRCA1/2 mutations in families with pancreatic cancer.
    Dagan E.
    Genet Test; 2008 Jun; 12(2):267-71. PubMed ID: 18439109
    [Abstract] [Full Text] [Related]

  • 2. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
    Stadler ZK, Saloustros E, Hansen NA, Schluger AE, Kauff ND, Offit K, Robson ME.
    Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693
    [Abstract] [Full Text] [Related]

  • 3. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [Abstract] [Full Text] [Related]

  • 4. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
    Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D.
    Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153
    [Abstract] [Full Text] [Related]

  • 5. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
    Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T.
    Am J Hum Genet; 1997 Mar; 60(3):505-14. PubMed ID: 9042909
    [Abstract] [Full Text] [Related]

  • 6. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
    Phelan CM, Kwan E, Jack E, Li S, Morgan C, Aubé J, Hanna D, Narod SA.
    Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
    [Abstract] [Full Text] [Related]

  • 7. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic.
    Shih HA, Couch FJ, Nathanson KL, Blackwood MA, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL.
    J Clin Oncol; 2002 Feb 15; 20(4):994-9. PubMed ID: 11844822
    [Abstract] [Full Text] [Related]

  • 8. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N, Kotar K, Foulkes WD.
    BMC Med Genet; 2003 Aug 11; 4():7. PubMed ID: 12911837
    [Abstract] [Full Text] [Related]

  • 9. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V.
    Neoplasma; 2006 Aug 11; 53(2):97-102. PubMed ID: 16575464
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer.
    Stadler ZK, Salo-Mullen E, Patil SM, Pietanza MC, Vijai J, Saloustros E, Hansen NA, Kauff ND, Kurtz RC, Kelsen DP, Offit K, Robson ME.
    Cancer; 2012 Jan 15; 118(2):493-9. PubMed ID: 21598239
    [Abstract] [Full Text] [Related]

  • 11. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
    Schorge JO, Mahoney NM, Miller DS, Coleman RL, Muller CY, Euhus DM, Tomlinson GE.
    Gynecol Oncol; 2001 Nov 15; 83(2):383-7. PubMed ID: 11606101
    [Abstract] [Full Text] [Related]

  • 12. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
    Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K.
    Nat Genet; 1996 Oct 15; 14(2):188-90. PubMed ID: 8841192
    [Abstract] [Full Text] [Related]

  • 13. Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel.
    Rennert G, Dishon S, Rennert HS, Fares F.
    Eur J Cancer Prev; 2005 Aug 15; 14(4):357-61. PubMed ID: 16030426
    [Abstract] [Full Text] [Related]

  • 14. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
    Manguoglu AE, Lüleci G, Ozçelik T, Colak T, Schayek H, Akaydin M, Friedman E.
    Hum Mutat; 2003 Apr 15; 21(4):444-5. PubMed ID: 12655560
    [Abstract] [Full Text] [Related]

  • 15. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R, Oefner P, Green L, Baruch RG, Wagner T, Kruglikova A, Haitchick S, Hofstra RM, Papa MZ, Mulder I, Rizel S, Bar Sade RB, Dagan E, Abdeen Z, Goldman B, Friedman E.
    Hum Mutat; 2000 Dec 15; 16(6):491-501. PubMed ID: 11102978
    [Abstract] [Full Text] [Related]

  • 16. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M, Silva A, Rubio L, Alvarez C, Torrealba C, Salinas M, Tapia T, Faundez P, Palma L, Riccio ME, Paredes H, Rodriguez M, Cruz A, Rousseau C, King MC, Camus M, Alvarez M, Carvallo P.
    Breast Cancer Res Treat; 2006 Jan 15; 95(1):81-7. PubMed ID: 16261400
    [Abstract] [Full Text] [Related]

  • 17. Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
    Rosenthal E, Moyes K, Arnell C, Evans B, Wenstrup RJ.
    Breast Cancer Res Treat; 2015 Jan 15; 149(1):223-7. PubMed ID: 25476495
    [Abstract] [Full Text] [Related]

  • 18. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod SA, Redston M, Gallinger S.
    Cancer Res; 2000 Jan 15; 60(2):409-16. PubMed ID: 10667595
    [Abstract] [Full Text] [Related]

  • 19. Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel.
    Laitman Y, Borsthein RT, Stoppa-Lyonnet D, Dagan E, Castera L, Goislard M, Gershoni-Baruch R, Goldberg H, Kaufman B, Ben-Baruch N, Zidan J, Maray T, Soussan-Gutman L, Friedman E.
    Breast Cancer Res Treat; 2011 Jun 15; 127(2):489-95. PubMed ID: 20960228
    [Abstract] [Full Text] [Related]

  • 20. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
    Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K.
    Nat Genet; 1996 May 15; 13(1):126-8. PubMed ID: 8673092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.